Companies: 10,795·Total market cap: $144.5T
Amarantus BioScience Holdings, Inc.

Amarantus BioScience Holdings, Inc.

AMBSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$36841
P/E Ratio—
52W High$0.0003
52W Low$0.00001
Overview

Amarantus BioScience Holdings, Inc. (AMBS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001424812 · AMBS · OTC · as of Jun 9, 2026

Filing snapshot

372
Total Filings
SEC STAFF ACTION
Latest Form
2022-09-09
Most Recent
2010
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001424812 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2016-05-16
Fiscal Year End
May 16, 2016
Accession No.
0001213900-16-013437
Primary Document
f10k2015_amarantusbioscience.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001424812 · Accession 0001213900-16-013437

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2016-06-01
View 10-Q on SEC
8-KCurrent Report
CURRENT REPORT
2017-05-09Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SEC STAFF ACTIONSEC STAFF ACTION
SEC STAFF ACTION
2022-09-09
View
SC 13D/ASC 13D/A
SC 13D/A
2022-04-18
View
SC 13D/ASC 13D/A
SC 13D/A
2022-04-18
View
SC 13D/ASC 13D/A
SC 13D/A
2022-04-18
View
SC 13DActivist Ownership Report
SC 13D
2020-10-09
View
SC 13DActivist Ownership Report
SC 13D
2020-10-05
View
SC 13DActivist Ownership Report
SC 13D
2020-10-05
View
1-A-W1-A-W
REQUEST FOR WITHDRAWAL OF OFFERING STATEMENT OF FORM 1-A
2020-01-10
View
1-A/A1-A/A
1-A/A
2020-01-09
View
1-A1-A
1-A
2020-01-09
View
1-A1-A
1-A
2019-09-27
View
DOSDOS
DOS
2018-11-27
View
DD
D
2018-03-12
View
15-12G15-12G
FORM 15
2017-12-04
View
8-KCurrent Report
CURRENT REPORT
2017-05-09
View
Showing 1–15 of 350 filingsForm 4 / 144 hidden· 372 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001424812  |  Exchange: OTC · Healthcare

Amarantus BioScience Holdings, Inc. (OTC: AMBS) has submitted 372 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2010. As a Healthcare sector company with CIK 0001424812, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Amarantus BioScience Holdings, Inc.'s most comprehensive regulatory disclosure. The most recent Amarantus BioScience Holdings, Inc. 10-K was filed on 2016-05-16 for fiscal year ending 2016. Historical AMBS 10-K annual reports are available from 2008 through 2016.

Investors researching Amarantus BioScience Holdings, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ACBM SEC Filings →NSPDF SEC Filings →BSSP SEC Filings →AFFY SEC Filings →DECN SEC Filings →ENDV SEC Filings →PRMD SEC Filings →ITMC SEC Filings →
→ AMBS Financials→ AMBS Earnings→ AMBS Insider Trades

Frequently Asked Questions

AMBS SEC Filings · 8 questions

Amarantus BioScience Holdings, Inc. (AMBS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 372 filings and access original documents at no cost. Amarantus BioScience Holdings, Inc.'s CIK is 0001424812.

AMBS SEC filingsAmarantus BioScience Holdings, Inc. SEC documentsfind AMBS 10-K